Musculoskeletal and Connective Tissue Diseases

1 clinical trials · Condition

Record	Firm	Date
A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (NCT02198651)	AbbVie	2015-01-05

Every clearance here is in the API, with alerts when new ones post.